Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Haddad

Showing results (671-680 of 698) with videos related to

Pageof 70
Sort By:
Gastroenterology|September 30, 2017
Hepatitis E Virus Lifecycle and Identification of 3 Forms of the ORF2 Capsid ProteinClaire Montpellier, Czeslaw Wychowski, Ibrahim M Sayed, et al.
Journal of Hematology & Oncology|May 2, 2023
Results of salvage therapy with mini-hyper-CVD and inotuzumab ozogamicin with or without blinatumomab in pre-B acute lymphoblastic leukemiaHagop Kantarjian, Fadi G Haddad, Nitin Jain, et al.
American Journal of Respiratory Cell and Molecular Biology|January 9, 2015
Notch Activation of Ca(2+) Signaling in the Development of Hypoxic Pulmonary Vasoconstriction and Pulmonary HypertensionKimberly A Smith, Guillaume Voiriot, Haiyang Tang, et al.
Blood Cancer Discovery|April 14, 2026
Integrated analysis of genomics, molecular responses and outcomes of CBF-AML with FLAG based therapy on a phase 2 trialJayastu Senapati, Hagop M Kantarjian, Edward Ayoub, et al.
The Lancet. Haematology|May 15, 2023
Mini-hyper-CVD plus inotuzumab ozogamicin, with or without blinatumomab, in the subgroup of older patients with newly diagnosed Philadelphia chromosome-negative B-cell acute lymphocytic leukaemia: long-term results of an open-label phase 2 trialElias Jabbour, Nicholas J Short, Jayastu Senapati, et al.
Leukemia|May 9, 2025
Characteristics and outcomes of newly diagnosed acute myeloid Leukemia with KMT2A rearrangementsAlex Bataller, Hannah E Goulart, Ghayas C Issa, et al.
The Journal of Clinical Investigation|May 27, 2021
Astrocytes propel neurovascular dysfunction during cerebral cavernous malformation lesion formationMiguel Alejandro Lopez-Ramirez, Catherine Chinhchu Lai, Shady Ibrahim Soliman, et al.
Molecular Psychiatry|April 23, 2021
Altered network and rescue of human neurons derived from individuals with early-onset genetic epilepsyPriscilla D Negraes, Cleber A Trujillo, Nam-Kyung Yu, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 30, 2025
Outcomes of Patients With IDH1-Mutated Myeloid Neoplasms Treated With OlutasidenibKelly S Chien, Sanam Loghavi, Koji Sasaki, et al.
Nature Communications|May 2, 2022
Transcription Factor 4 loss-of-function is associated with deficits in progenitor proliferation and cortical neuron contentFabio Papes, Antonio P Camargo, Janaina S de Souza, et al.
Pageof 70

Showing results (671-680 of 698) with videos related to

Sort By:
Pageof 70
Gastroenterology|September 30, 2017
Hepatitis E Virus Lifecycle and Identification of 3 Forms of the ORF2 Capsid ProteinClaire Montpellier, Czeslaw Wychowski, Ibrahim M Sayed, et al.
Journal of Hematology & Oncology|May 2, 2023
Results of salvage therapy with mini-hyper-CVD and inotuzumab ozogamicin with or without blinatumomab in pre-B acute lymphoblastic leukemiaHagop Kantarjian, Fadi G Haddad, Nitin Jain, et al.
American Journal of Respiratory Cell and Molecular Biology|January 9, 2015
Notch Activation of Ca(2+) Signaling in the Development of Hypoxic Pulmonary Vasoconstriction and Pulmonary HypertensionKimberly A Smith, Guillaume Voiriot, Haiyang Tang, et al.
Blood Cancer Discovery|April 14, 2026
Integrated analysis of genomics, molecular responses and outcomes of CBF-AML with FLAG based therapy on a phase 2 trialJayastu Senapati, Hagop M Kantarjian, Edward Ayoub, et al.
The Lancet. Haematology|May 15, 2023
Mini-hyper-CVD plus inotuzumab ozogamicin, with or without blinatumomab, in the subgroup of older patients with newly diagnosed Philadelphia chromosome-negative B-cell acute lymphocytic leukaemia: long-term results of an open-label phase 2 trialElias Jabbour, Nicholas J Short, Jayastu Senapati, et al.
Leukemia|May 9, 2025
Characteristics and outcomes of newly diagnosed acute myeloid Leukemia with KMT2A rearrangementsAlex Bataller, Hannah E Goulart, Ghayas C Issa, et al.
The Journal of Clinical Investigation|May 27, 2021
Astrocytes propel neurovascular dysfunction during cerebral cavernous malformation lesion formationMiguel Alejandro Lopez-Ramirez, Catherine Chinhchu Lai, Shady Ibrahim Soliman, et al.
Molecular Psychiatry|April 23, 2021
Altered network and rescue of human neurons derived from individuals with early-onset genetic epilepsyPriscilla D Negraes, Cleber A Trujillo, Nam-Kyung Yu, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 30, 2025
Outcomes of Patients With IDH1-Mutated Myeloid Neoplasms Treated With OlutasidenibKelly S Chien, Sanam Loghavi, Koji Sasaki, et al.
Nature Communications|May 2, 2022
Transcription Factor 4 loss-of-function is associated with deficits in progenitor proliferation and cortical neuron contentFabio Papes, Antonio P Camargo, Janaina S de Souza, et al.
Pageof 70